Cipro® XR Tablets 1000 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

CompletedNCT00650351

Mylan Pharmaceuticals IncHealthy

Start: 2005-10-31End: 2005-10-31Updated: 2024-04-24

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

CompletedNCT00649662

Mylan Pharmaceuticals IncHealthy

Start: 2005-10-31End: 2005-10-31Updated: 2024-04-24